(Q51964377)

English

Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.

scientific article published on 24 April 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

0 references

0 references

author name string

A Boberg

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

S Gaunitz

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

A Bråve

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

B Wahren

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

N Carlin

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

language of work or name

0 references

publication date

24 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

26

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

40

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

5079-5082

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

Novel peptide-based HIV-1 immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Possible therapeutic vaccine strategy against human immunodeficiency virus escape from reverse transcriptase inhibitors studied in HLA-A2 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Transmission of HIV-1 drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Vaccination against drug resistance in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.096

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.03.096

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18514370

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51964377&oldid=1368941958"